50
Participants
Start Date
June 15, 2025
Primary Completion Date
April 1, 2026
Study Completion Date
June 1, 2026
Intravenous Ketamine Infusions
The patients received a single intravenous infusion of esketamine (0.2 mg/kg), which was added to 50 ml of normal saline and administered via a micro-infusion pump over 40 minutes.
Intravenous normal saline
The patients received a single intravenous infusion of 50 ml normal saline via a micro-infusion pump over 40 minutes
Oral Duloxetine 60mg
Patients received 60 mg/day of oral duloxetine as maintenance therapy for depression.
Huazhong University of Science and Technology
OTHER